Sterile ampoule of L-carnitine for transcutaneous application whose mechanism of action increases the efficacy of other products.
During the lipolysis, triglycerides decompose into two fractions: glycerol and fatty acids. These non-esterified fatty acids have limited capacity to penetrate the mitochondria and need a physiological carrier to perform this step. This transporter is L-carnitine, thanks to which activated fatty acids are diverted towards oxidation and are not used by the body in the neoformation of triglycerides, leading to reduced cytoplasmic bioavailability of activated fatty acids. The mechanism of action improves the efficacy of other products with lipolytic effects to increase intra-adipose cAMP levels.
